X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sun Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-16
TEVA PHARMA
Dec-13
SUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2012,674-   
Low Rs7062,323-   
Sales per share (Unadj.) Rs117.51,534.8-  
Earnings per share (Unadj.) Rs19.695.9-  
Cash flow per share (Unadj.) Rs23.8219.9-  
Dividends per share (Unadj.) Rs1.0083.93-  
Dividend yield (eoy) %0.13.4 3.1%  
Book value per share (Unadj.) Rs130.51,704.9-  
Shares outstanding (eoy) m2,406.60848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.11.6 498.6%   
Avg P/E ratio x48.726.1 186.7%  
P/CF ratio (eoy) x40.111.4 352.5%  
Price / Book Value ratio x7.31.5 498.6%  
Dividend payout %5.187.5 5.8%   
Avg Mkt Cap Rs m2,294,8132,118,923 108.3%   
No. of employees `00014.744.9 32.8%   
Total wages/salary Rs m47,9710-   
Avg. sales/employee Rs Th19,169.828,958.0 66.2%   
Avg. wages/employee Rs Th3,253.00-   
Avg. net profit/employee Rs Th3,197.91,809.0 176.8%   
INCOME DATA
Net Sales Rs m282,6971,301,518 21.7%  
Other income Rs m6,1700-   
Total revenues Rs m288,8671,301,518 22.2%   
Gross profit Rs m83,239356,421 23.4%  
Depreciation Rs m10,135105,203 9.6%   
Interest Rs m4,76925,564 18.7%   
Profit before tax Rs m74,505225,655 33.0%   
Minority Interest Rs m-11,1261,025 -1,085.3%   
Prior Period Items Rs m-190-   
Extraordinary Inc (Exp) Rs m-6,852-148,130 4.6%   
Tax Rs m9,349-2,755 -339.3%   
Profit after tax Rs m47,15981,305 58.0%  
Gross profit margin %29.427.4 107.5%  
Effective tax rate %12.5-1.2 -1,027.8%   
Net profit margin %16.76.2 267.0%  
BALANCE SHEET DATA
Current assets Rs m308,646879,040 35.1%   
Current liabilities Rs m132,477766,598 17.3%   
Net working cap to sales %62.38.6 721.3%  
Current ratio x2.31.1 203.2%  
Inventory Days Days8391 91.3%  
Debtors Days Days8896 91.5%  
Net fixed assets Rs m133,606425,104 31.4%   
Share capital Rs m2,4073,204 75.1%   
"Free" reserves Rs m266,9090-   
Net worth Rs m314,0421,445,740 21.7%   
Long term debt Rs m31,167665,495 4.7%   
Total assets Rs m542,1962,974,386 18.2%  
Interest coverage x16.69.8 169.2%   
Debt to equity ratio x0.10.5 21.6%  
Sales to assets ratio x0.50.4 119.2%   
Return on assets %9.63.6 266.6%  
Return on equity %15.05.6 267.0%  
Return on capital %17.84.9 360.0%  
Exports to sales %14.00-   
Imports to sales %3.10-   
Net fx Rs m20,5880-   
CASH FLOW
From Operations Rs m67,694207,395 32.6%  
From Investments Rs m-44,549-73,488 60.6%  
From Financial Activity Rs m-19,243-248,784 7.7%  
Net Cashflow Rs m3,902-114,878 -3.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare SUN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SUN PHARMA With: GLENMARK PHARMA  CIPLA  AJANTA PHARMA  MERCK LTD  ABBOTT INDIA  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS